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Abstract
Objectives
This study aims to identify the risk factors for intensive care (IC) in severe malaria patients
admitted to the “Lazzaro Spallanzani” National Institute for Infectious Diseases, Rome, Italy.
Methods
All patients with confirmed severe malaria and hospitalized between 2007 and 2015 were
included in the analysis and stratified into two groups: those requiring IC and those who did
not. Five prognostic malaria scores were estimated; clinical severity at IC unit admission
was assessed using the Sequential Organ Failure Assessment and the quick-Sequential
Organ Failure Assessment scores. Univariate and multivariate analysis were performed to
assess factors independently associated to IC.
Results
A total of 98 severe malaria patients were included; 10 of them required IC. There were no
deaths or sequelae. Patients requiring IC had higher severity scores. At the multivariate
analysis, only the number of World Health Organization criteria and the aspartate amino-
transferase value were independently associated with the need of IC.
Conclusions
An early and accurate assessment of the severity score is essential for the management of
severe malaria patients.
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Introduction
Imported malaria is a substantial clinical and epidemiological problem in many European
countries currently considered as malaria-free. In Europe, approximately 6000 imported
malaria cases are reported annually, with 10% of them progressing towards severe malaria [1].
The case-fatality rate of adequately treated severe malaria, due to Plasmodium falciparum is
about 10–20% while it is almost 100% if left untreated [2]; among patients admitted to inten-
sive care unit (ICU), such case-fatality rate ranges between 5 to 10% [3]. Individuals from non-
endemic countries travelling to high malaria endemic countries are immunologically naïve as
they have not been previously exposed to the infection. For this reason, when infected, they
may evolve rapidly towards severe malaria with high parasite densities, multi-organ involve-
ment, and eventually death [4–6]. Therefore, identifying among these patients those with a
higher risk of adverse outcome may improve their management and thus reduce the risk of
death. The aim of this study was to assess the risk factors associated with the need of IC. For
this purpose, the clinical records of a cohort of severe malaria patients admitted over 8 years at
the “Lazzaro Spallanzani” National Institute for Infectious Diseases (INMI), Rome, Italy were
analysed.
Methods
In this single-centre cross sectional study, we retrospectively recruited a total number of 98
patients consecutively hospitalized with confirmed severe malaria at the INMI Spallanzani,
Rome, Italy, from January 2007 to December 2015. The INMI Spallanzani is a 200-bed hospital
dealing mainly with infectious and tropical diseases with a 10-bed ICU. This study was
approved by the Ethic Committee of the INMI Spallanzani (ethics number 38/2016). Inclusion
criteria: age>18 years old, written informed consent at hospital admission from the patient or
next of kin if patient unable, severe confirmed malaria diagnosis. Severe malaria was diagnosed
in presence of P. falciparum asexual parasitaemia and at least one clinical (impaired conscious-
ness or unarousable coma; prostration; failure to feed; multiple convulsions–more than two
episodes in 24 hours; respiratory distress; circulatory collapse or shock; clinical jaundice and
evidence of other vital organ dysfunctions; haemoglobinuria; abnormal spontaneous bleeding;
pulmonary oedema) or laboratory (hypoglycaemia; metabolic acidosis; severe anaemia; hyper-
parasitaemia; renal impairment hyperlactataemia) criterion in absence of any other obvious
cause [7]. For Plasmodium vivax, all the criteria were applied with the only exception of hyper-
parasitaemia [7]. Demographic characteristics, medical and travel history, clinical presenta-
tion, anti-malarial and supportive treatment, parasitaemia before and during treatment,
complications during treatment, adverse drug reactions, clinical outcome (survival, death or
sequelae) at day 28 post-treatment were collected for all patients from the clinical record. In
addition, the time to reduce parasite density below 1% and parasite clearance were also col-
lected. Patients were divided into two groups, namely those requiring and those not requiring
intensive care (ICU and non-ICU, respectively). The ICU criteria for admission were: Glasgow
Coma Scale<11, presence of multiple convulsions, respiratory distress with a PaO2/FiO2
Ratio <100, conditions requiring mechanical or non-invasive ventilation, circulatory collapse
or shock and/or mean artherial pressure <70 mmHg requiring vasopressor drugs, all those
conditions requiring close monitoring and/or prolonged sedation. For each patient, five prog-
nostic malaria scores were calculated: the Malaria Score for Adults (MSA) [8], the Coma Aci-
dosis Malaria score (CAM) [9], the Respiratory rate-based CAM score (R-CAM) [9], the
Malaria Severity Score (MSS) [10] and the GCRBS (Glasgow coma scale, Creatinine, Respira-
tory rate, Bilirubin, Systolic blood pressure) Score [11]. Clinical severity at ICU admission was
Malaria and intensive care
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also assessed using the Sequential Organ Failure Assessment (SOFA) score [12] and quick-
SOFA (q-SOFA) score [13].
Statistical analysis
Comparison of continuous data between 2 groups were analysed with the Student’s t test or
Mann-Whitney test, as appropriate. Fisher exact test was used to evaluate age, gender and
WHO criteria distribution. Pearson’s correlation and linear regression were used to evaluate
the correlation between malarial and non-malarial scores. Data were expressed as median
(interquartile range, IQR) or mean ± standard deviation (M±SD), as appropriate. Univariate
and multivariate analyses were performed to analyse the factors independently associated to
admission in ICU. The final multivariate model was selected with a forward stepwise variable
selection procedure. In the multivariate analysis, a stepwise logistic regression model was fit-
ted. A p value of<0.05 was considered statistically significant. Statistical analyses were per-
formed using GraphPad PRISM and Stata Corp. 2013. Stata Statistical Software: Release 13.
College Station, TX: StataCorp LP.
Results
Study population
From 2007 to 2015, a total of 98 patients with severe malaria were admitted; 10 of them requir-
ing IC (Table 1).
Patients requiring IC showed longer length of hospitalization and parasite clearance time
compared to the other group. Notably, there were 5 cases of P. vivax severe malaria, including
one requiring IC. Overall, the reasons for IC were cerebral malaria (7 cases), shock (6 cases)
and acute respiratory distress syndrome (4 cases). The presence of 2 concurrent criteria for IC
was observed in seven patients. All patients who required IC were treated with either intrave-
nous artesunate (2.4 mg/kg at 0, 12, 24 and 48 hours, in 6 cases) or quinine (20 mg/kg loading
dose followed by 10 mg/kg for a total of 48 hours, in 4 cases). Moreover, all ICU patients
received antibiotic treatment for bacterial infections (3 central venous catheter-associated
blood stream infections due to multidrug resistant Acinetobacter baumannii, methicillin-resis-
tant Staphylococcus aureus, and Candida albicans, 6 ventilator associated pneumoniae, 1 cathe-
ter-associated urinary tract infection). In addition, eight patients needed mechanical
ventilation for acute lung injury (6 cases) and acute respiratory distress syndrome (2 cases), 6
patients were treated with vasopressor drugs for shock and 2 patients with continuous veno-
venous hemodiafiltration for acute renal failure. At 28-day follow-up, no deaths or docu-
mented sequelae were reported.
Malarial and non-malarial severity scores
The different malarial scores were estimated for all 98 severe malaria patients; those who
required IC had higher scores than the others (Table 2).
The relation between SOFA, q-SOFA and malarial severity scores was evaluated and a posi-
tive linear regression was found between SOFA and GCRBS only (p = 0.01, r2 = 0.58) (Fig 1).
ICU versus non-ICU patients
Mean age, baseline parasite density, platelet count, haemoglobin and serum creatinine levels
were similar between ICU and non-ICU patients; ICU patients had a slower parasite clearance
(127.2±19 vs 84.7±4.6 hours, p = 0.006) and higher total bilirubin (4.8±1.2 vs 2±0.16 mg/dl,
p<0.0001), aspartate aminotransferase (AST, 159.3±34 vs 66.5±7.6 U/L, p = 0.0003) (Fig 2A)
Malaria and intensive care
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and alanine aminotransferase (ALT, 102.9±19.3 vs 61.3±7.3 U/L, p = 0.07). All ICU patients
had more than 3 WHO criteria for severe malaria while the other patients met only one crite-
rion (3.8±0.2 vs 1.3±0.11, p<0.001) (Fig 2B): specifically, the presence of neurological
Table 1. Severe malaria patients by Intensive Care need (%).
Variables ICU NON-ICU p
(n = 10) (n = 88)
Male 8 (80) 71 (80.7) 0.421
Age (years) (M±SD) 45 ± 14 38 ± 13 0.142
Country of origin
- European 6 (60) 43 (49)
- Immigrant 4 (40) 41 (46.5) 0.223
- Visitors from endemic country 0 4 (4.5)
Comorbidities
- HIV 1 (10) 4 (4.5)
- Chronic Viral Hepatitis 1 (10) 1 (1.1)
- Arterial Hypertension 1 (10) 10 (11.4)
- COPD 0 4 (4.45) 0.443
- Splenectomy 1 (10) 0
- Cancer 0 1 (1.1)
- Hypothyroidism 0 2 (2.3)
Antimalarial chemoprophylaxis (n, %) 0 9 (10.2) 0.552
Area of infection (n, %):
West Africa 10 (100) 65 (73.9) 0.944
Purpose of travel (n, %)
- VRFs 2 (20) 30 (34.1)
- Tourism 3 (30) 25 (28.4) 0.876
- Business 4 (40) 13 (14.8)
- Humanitarian aid 1 (10) 10 (11.4)
- Other 0 10 (11.4)
Plasmodium (n, %)
- Falciparum 9 (90) 83 (94.3)
- Vivax 1 (10) 4 (4.5) 0.554
- Mixed Infection 0 1 (1.1)
Delay of diagnosis (days) (M±SD) 4.5 ± 0.8 4.2 ± 0.5 0.851
Delay of treatment (days) (M±SD) 4.9 ± 0.7 4.8 ± 0.5 0.951
Days of hospitalization (M±SD) 25.6 ± 7.4 7.1 ± 0.5 0.0001
Basal % parasitemia (Median, IQR) 7 (2–7) 5 (0.9–7) 0.811
Time to parasitaemia <1% (hours) (M±SD) 67.2 ± 11.7 51.5 ± 3.0 0.122
Time to parasite clearance (hours) (M±SD) 127.2 ± 19.6 84.7 ± 4.6 0.006
Antimalarial Treatment during Hospitalization
- Artesunate (iv) 6 (60) 17 (19.3)
- Quinine (iv) 4 (40) 17 (19.3)
- Arthemeter (im) 0 11 (12.5) 0.434
- Quinine (oral) 0 17 (19.3)
- Dihydroartemisinin/piperaquine 0 24 (27.4)
- Cloroquine 0 2 (2.2)
ICU: Intensive Care Unit; im: intramuscular; iv: intravenous; M: mean; SD: Standard deviation; IQR: interquartile range, COPD: chronic obstructive pulmonary disease,
VRFs:Visiting Relatives and Friends.
https://doi.org/10.1371/journal.pone.0225135.t001
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(p<0.001), liver (p = 0.03) or respiratory involvement (p<0.001) as single WHO criterion of
severe malaria was associated to IC need.
Univariate analysis showed that the number of WHO criteria (p<0.001), time to parasite
clearance (p = 0.012), levels of serum AST (p = 0.004) and bilirubin (p = 0.003) at admission
were associated with IC. Multivariate analysis showed that the number of WHO criteria (Odd
Ratio [OR] = 2.58; confidence interval [CI] = 1.36–4.91; p = 0.004) and AST value (OR = 1.01;
CI = 1.00–1.02; p = 0.037) were independently associated with IC (Table 3).
Discussion
Malaria remains a substantial problem in non-endemic countries. In this series of patients
recruited over a 8-year period, 10 patients required IC, with a 4-day median delay of malaria
diagnosis; all of them had been infected in West Africa and none of them received anti-malaria
chemoprophylaxis. In a non-endemic country, any imported severe malaria case is a medical
emergency, often complicated by a delayed access to care, diagnosis and initiation of specific
parenteral therapy. The capacity of the different national health systems for reporting malaria
cases varies substantially and depends on the capacity for a reliable diagnosis [14]. Unspecific
febrile symptoms and low quality microscopy reading in non-specialised laboratories can
Table 2. Malarial score: ICU vs non-ICU.
Malarial Scores (mean) ICU NON-ICU p
MSA 5.4 0.9 <0.001
CAM 1.6 0.4 0.008
R-CAM 2.1 0.3 0.002
MSS 11.9 1 <0.001
GCRBS 2.9 0.3 <0.001
ICU: Intensive Care Unit, MSA: Malaria Score for Adults, CAM: Coma Acidosis Malaria score, R-CAM: Respiratory
rate-based CAM score, MSS: Malaria Severity Score, GCRBS Score: Glasgow coma scale, Creatinine, Respiratory rate,
Bilirubin, Systolic blood pressure.
https://doi.org/10.1371/journal.pone.0225135.t002
Fig 1. Malarial and non-malarial severity scores. A positive linear regression was found between Sequential Organ
Failure Assessment score (SOFA) and GCRBS Score (Glasgow coma scale, Creatinine, Respiratory rate, Bilirubin,
Systolic blood pressure).
https://doi.org/10.1371/journal.pone.0225135.g001
Malaria and intensive care
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delay diagnosis [15]. In this series of patients, P. falciparum was the main causing species
although there were some P. vivax cases, with one of them requiring IC. There have been
increasing reports of severe malaria caused by P. vivax [2].
Severe malaria may rapidly evolve to an unfavourable prognosis requiring IC with a case-
fatality rate between 5 and 10%. Therefore, identifying severe malaria patients at higher risk of
death is of paramount importance. However, not all WHO criteria have the same predictive
value for the early identification of patients with unfavourable prognosis. In the 400-patient
cohort study conducted in France by Bruneel et al., three baseline variables independently pre-
dicted death: older age, coma and high parasite density [16]. In our study, five prognostic
malaria scores were calculated for each ICU patient (MSA, CAM, R-CAM, MSS, GCRBS
score) and clinical severity at ICU admission was assessed using both SOFA and q-SOFA
scores. In this study, most ICU patients had a medium-high SOFA score with a high SOFA-
related mortality predictive value. In addition, there was a positive correlation between SOFA,
a non-specific malaria score, and GCRBS, a specific malaria score. An early assessment of the
severity status of the patient by specific score is required at admission to rapidly decide
whether the patient needs to be admitted in ICU. Applying both malaria-specific (GCRBS)
Fig 2. Aspartate aminotransferase levels (A) and N_WHO criteria (B) between ICU and non-ICU patients. Intensive Care Unit (ICU) group
showed a significantly higher aspartate aminotransferase (AST) value (A) and higher number of WHO criteria (B) compared to non-ICU group.
https://doi.org/10.1371/journal.pone.0225135.g002
Table 3. Logistic regression model to evaluate risk factors associated with IC.
Univariate Multivariate�
OR (95% CI) p OR (95% CI) p
N_WHO criteria 4.00 (1.96–8.16) <0.001 2.58 (1.36–4.92) 0.004
Basal parassitemia 0.97 (0.75–1.24) 0.816
Time parasitemia clearance 1.01 (1.00–1.03) 0.012
Platelet count 1.00 (0.99–1.00) 0.204
Haemoglobin 0.83 (0.65–1.07) 0.166
Creatinine 1.72 (0.39–7.51) 0.466
Bilirubine 1.74 (0.12–2.52) 0.003 1.52 (0.93–2.47) 0.089
AST 1.10 (1.00–1.01) 0.004 1.01 (1.00–1.02) 0.037
ALT 1.0 (0.99–1.01) 0.092
OR: Odds Ratio; CI: confident interval;
�with forward stepwise variable selection procedure, WHO: World Health Organization, AST: aspartate aminotransferase, ALT: alanine aminotransferase.
https://doi.org/10.1371/journal.pone.0225135.t003
Malaria and intensive care
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and general (SOFA) scores to severe malaria patients could be the best approach to assess the
need for IC.
The findings of this study have few limitations. First, this is a retrospective and cross-sec-
tional study conducted in a single centre. Second, the small number of enrolled patients, espe-
cially those requiring ICU admission, could affect the generalization of our results to a wider
population. However, our results are consistent with data from previous studies. In a recent
review on the clinical management of imported severe malaria in adults, the authors recom-
mended an assessment by ICU staff for all patients with malaria even if presenting one severity
criterion, only [17]. Moreover, patients with uncomplicated malaria but at risk of rapidly
evolving towards severe malaria should be under continuous monitoring; a>2 q-SOFA score
should be considered as an indication for ICU admission [17]. In our case series, patients
requiring IC had a higher number of WHO criteria than the other group, and cerebral malaria,
liver and respiratory failures were the most frequent observed complications. Indeed, at multi-
variate analysis, the number of WHO criteria and the AST level were independently associated
with ICU admission. A prompt intravenous antimalarial regimen with adequate supportive
therapy warranted a favourable outcome: the WHO guidelines for the treatment of severe
malaria recommend the use of intravenous artesunate for at least the first 24 hours [2]. Such
recommendation is based on the results of two large trials carried out in malaria-endemic
countries that showed artesunate superiority to quinine in terms of efficacy (rapid decay of
parasitaemia), safety (no major adverse events) and better survival [18,19]. All our patients
requiring IC were treated with either quinine (4 patients before 2010 when parenteral artesu-
nate was unavailable) or artesunate. All patients recovered without any complications or
sequelae.
Conclusions
Considering that severe malaria may rapidly evolve to an unfavourable prognosis, a prompt
and accurate evaluation for ICU admission is needed. According to our results, the assessment
of both malarial and non-malarial severity scores may contribute to the proper management
of severe malaria. Specifically, the number of WHO criteria and AST plasma level can predict
the need of intensive care.
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